Hong Kong Auto Stock News

CLP Holdings earnings spark fresh look at the stock CLP Holdings (SEHK:2) has drawn investor attention after reporting half year 2026 earnings, with sales at HK$42,856 million and net income of HK$6,104 million on slightly higher earnings per share. See our latest analysis for CLP Holdings. Following the results, CLP Holdings is trading at HK$77.6, with an 11.02% year to date share price return and a 21.42% 1 year total shareholder return, suggesting momentum has been building over time. If...

Insiders who purchased CN¥40.9m worth of Future Machine Limited ( HKG:1401 ) shares over the past year recouped some of...

The recent price decline of 18% in Feiyang International Holdings Group Limited's ( HKG:1901 ) stock may have...

With the business potentially at an important milestone, we thought we'd take a closer look at Everest Medicines...

Bar Pacific Group Holdings Limited's ( HKG:8432 ) strong earnings report was rewarded with a positive stock price move...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Investors were disappointed with Success Dragon International Holdings Limited's ( HKG:1182 ) earnings, despite the...

The recent 14% drop in Qing Hua Holding Group Company Limited's ( HKG:8082 ) stock could come as a blow to insiders who...

From what we can see, insiders were net buyers in Tomson Group Limited's ( HKG:258 ) during the past 12 months. That...

Hang Lung Properties Limited ( HKG:101 ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is two...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Uni-President China Holdings (SEHK:220) is in focus after reporting half-year 2026 earnings, with sales of CN¥17,321 million and net income of CN¥1,402 million, along with higher basic earnings per share from continuing operations. See our latest analysis for Uni-President China Holdings. The HK$7.70 share price has moved up in the short term, with a 1 day share price return of 3.08% and a 30 day share price return of 3.22%, although the 1 year total shareholder return is down 14.59% while...

Global inflation updates, regional GDP releases and fresh signals from central banks are about to test sentiment toward Asia’s consumer driven stocks. When money shifts on the back of data like US July CPI and China credit figures, some companies tied to everyday spending can move quickly. This article walks through three Asia Consumer Discretionary Stocks from the screener that appear most exposed to these catalysts, and why that matters for your portfolio watchlist. The stocks highlighted...

Wharf Real Estate Investment entered this earnings day with the stock up strongly over the past month, yet still carrying a reputation for losses and a stretched valuation. The headline today is simple. The company is still loss making, but the earnings hit is now much smaller than in recent halves. Net income for the first half of 2026 shows a loss of HK$176 million on revenue of HK$6,340 million. The market now has to decide whether this softer loss justifies a price that already embeds a...

In a week marked by mixed performances across major U.S. stock indexes and ongoing volatility in AI-related shares, global markets have been navigating the complexities of economic indicators and central bank decisions. As investors seek opportunities amid these fluctuations, identifying undervalued stocks becomes crucial, especially those that may offer potential value despite current market uncertainties.

InnoCare Pharma (SEHK:9969) is back in focus after China’s NMPA granted Breakthrough Therapy Designation to its orelabrutinib and mesutoclax combination for previously treated marginal zone lymphoma, following strong clinical data shared at ASCO 2026. See our latest analysis for InnoCare Pharma. The Breakthrough Therapy Designation sits against a share price of HK$13.8, with a year to date share price return of 10.4% and a three year total shareholder return of 97.14%, even though the one...

Asian markets have recently experienced fluctuations, influenced by global economic factors such as AI-related stock volatility and central bank policy decisions. For investors looking beyond established giants, penny stocks—often representing smaller or newer companies—can still present intriguing opportunities. Though the term "penny stocks" may seem outdated, these investments can offer a blend of affordability and potential growth when supported by strong financial health.

We wouldn't blame China New Energy Limited ( HKG:1156 ) shareholders if they were a little worried about the fact that...

Shareholders of Techtronic Industries Company Limited ( HKG:669 ) will be pleased this week, given that the stock price...

Chow Tai Fook Jewellery Group (SEHK:1929) recently reported unaudited sales for the quarter to June 30, 2026, with group retail sales value up 15.1% year on year, drawing fresh attention to the stock. See our latest analysis for Chow Tai Fook Jewellery Group. The June quarter sales update has coincided with a pick up in momentum for Chow Tai Fook Jewellery Group, with a 1 month share price return of 8.27% and a 3 year total shareholder return of 15.33%. This is despite the 1 year total...

China Shanshui Cement Group’s share price sat at HK$0.241 going into the close on 6 August, with the stock flat over 7 days and down sharply over 3 months. The real story in this earnings print is the profit squeeze. Revenue in Q2 2026 reached ¥2,898.6m, yet the company still reported a net loss of ¥9.4m, capping a trailing twelve month loss of ¥1,458.5m. That mix of low sales multiple and ongoing losses is what the market is wrestling with, and it sets the emotional tone for how this result...

Hongkong and Shanghai Hotels stock finished today at HK$5.92, roughly flat over the week after a small 7 day pullback and a stronger 30 day run. The share price moved while the real story sat in the earnings. The group has reported a return to profit over the last 12 months, supported by a HK$414.0m one off gain, and now trades on a P/E of 15.6x. For short term traders the question is how durable that profit looks once the one off fades. For longer term holders the focus shifts to whether the...